Date I, Kawamura K, Nakashima H
Department of Neurological Surgery, Okayama University Medical School, Japan.
Exp Brain Res. 1988;73(1):15-22. doi: 10.1007/BF00279656.
Using an immunocytochemical method, we examined the immunological responses of adult mice to intracerebellar syngeneic and allogeneic fetal mouse brainstem transplants (embryonic days 12-14). Syngeneic grafts and major histocompatibility complex (MHC)-compatible and non-MHC-incompatible allogeneic grafts survived well, showing no histological signs of rejection even 6 months after transplantation, and with no expression of MHC antigens being observed in any of the grafts. However, most cases of both MHC- and non-MHC-incompatible allografts showed rejection responses, such as marked neovascularization, cellular infiltration and necrosis, two weeks to one month after transplantation. In animals showing rejection, Class I MHC antigens were found on grafted neuronal tissue. An increased number of reactive astrocytes was also observed in the grafts. High levels of Class I antigen expression and prominent gliosis correlated with vigorous cellular infiltration. A quantitative analysis of T cell subsets in the animals showing rejection revealed that the L3T4/Lyt-2 ratio was 1.02 +/- 0.21 (mean +/- S.D.), indicating that helper/inducer and cytotoxic/suppressor T cells appeared equally in the rejection of MHC- and non-MHC-incompatible allografts. We consider that in these experiments, the brain was not completely an immunologically privileged site, and that MHC- and non-MHC-incompatible intraparenchymal neural transplants were not shielded from host immune surveillance.
我们采用免疫细胞化学方法,检测成年小鼠对小脑内同基因和异基因胎鼠脑干移植(胚胎第12 - 14天)的免疫反应。同基因移植以及主要组织相容性复合体(MHC)相容且非MHC不相容的异基因移植存活良好,即使在移植后6个月也未显示出排斥的组织学迹象,并且在任何移植组织中均未观察到MHC抗原的表达。然而,大多数MHC和非MHC不相容的异基因移植在移植后两周至一个月表现出排斥反应,如明显的新生血管形成、细胞浸润和坏死。在出现排斥反应的动物中,在移植的神经元组织上发现了I类MHC抗原。在移植组织中还观察到反应性星形胶质细胞数量增加。高水平的I类抗原表达和显著的胶质增生与强烈的细胞浸润相关。对出现排斥反应的动物的T细胞亚群进行定量分析显示,L3T4/Lyt - 2比值为1.02±0.21(平均值±标准差),表明辅助/诱导性T细胞和细胞毒性/抑制性T细胞在MHC和非MHC不相容的异基因移植排斥反应中出现的比例相当。我们认为,在这些实验中,脑并非完全是一个免疫特惠部位,并且MHC和非MHC不相容的实质内神经移植无法免受宿主免疫监视。